WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2023)
Top pharmaceutical stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
VTRS
VIATRIS INC
$11.24B2.56%31.60%$0.1200$0.2447%02023-12-15
NBIX
NEUROCRINE BIOSCIENCES INC
$11.51BN/A0.00%N/AN/AN/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$834.84MN/A0.00%N/AN/AN/AN/A
KMDA
KAMADA LTD
$208.47MN/A0.00%N/AN/AN/AN/A
ANIP
ANI PHARMACEUTICALS INC
$1.03BN/A0.00%N/AN/AN/AN/A
LNTH
LANTHEUS HOLDINGS INC
$5.05BN/A0.00%N/AN/AN/AN/A
SCYX
SCYNEXIS INC
$64.00MN/A0.00%N/AN/AN/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$360.47MN/A0.00%N/AN/AN/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$399.77M4.86%92.30%$0.1200$0.4876%02023-12-20
TXMD
THERAPEUTICSMD INC
$28.98MN/A0.00%N/AN/AN/AN/A
CRON
CRONOS GROUP INC
$800.34MN/A0.00%N/AN/AN/AN/A
AMPH
AMPHASTAR PHARMACEUTICALS INC
$2.77BN/A0.00%N/AN/AN/AN/A
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$15.37MN/A125.00%N/AN/AN/AN/A
RDY
DR REDDYS LABORATORIES LTD
$11.59B1.40%N/A$0.4877$0.9826%0
AGRX
AGILE THERAPEUTICS INC
$5.43MN/A0.00%N/AN/AN/AN/A
ZTS
ZOETIS INC
$82.24B0.84%30.50%$0.3750$1.5014%0
PCRX
PACIRA BIOSCIENCES INC
$1.29BN/A0.00%N/AN/AN/AN/A
ACRX
ACELRX PHARMACEUTICALS INC
$12.95MN/A0.00%N/AN/AN/AN/A
ETON
ETON PHARMACEUTICALS INC
$94.94MN/A0.00%N/AN/AN/AN/A
HROW
HARROW INC
$326.95MN/A0.00%N/AN/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$77.27MN/A0.00%N/AN/AN/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.51BN/A0.00%N/AN/AN/AN/A
PROC
PROCAPS GROUP SA
$292.78MN/A0.00%N/AN/AN/AN/A
ZOM
ZOMEDICA CORP
$166.59MN/A0.00%N/AN/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.78BN/A0.00%N/AN/AN/AN/A
DCPH
DECIPHERA PHARMACEUTICALS INC
$1.04BN/A0.00%N/AN/AN/AN/A
TLRY
TILRAY BRANDS INC
$1.39BN/A0.00%N/AN/AN/AN/A
ITCI
INTRA-CELLULAR THERAPIES INC
$6.05BN/A0.00%N/AN/AN/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$7.56MN/A0.00%N/AN/AN/AN/A
SIGA
SIGA TECHNOLOGIES INC
$398.82M8.02%-562.50%$0.4500$0.4589%0
ALKS
ALKERMES PLC
$4.05B4.41%0.00%$1.0700$1.0771%0
AYTU
AYTU BIOPHARMA INC
$13.03MN/A0.00%N/AN/AN/AN/A
EOLS
EVOLUS INC
$557.22MN/A0.00%N/AN/AN/AN/A
FTLF
FITLIFE BRANDS INC
$90.87MN/A0.00%N/AN/AN/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$1.43BN/A0.00%N/AN/AN/AN/A
PETQ
PETIQ INC
$533.81MN/A0.00%N/AN/AN/AN/A
ASRT
ASSERTIO HOLDINGS INC
$107.92MN/A0.00%N/AN/AN/AN/A
DRRX
DURECT CORP
$19.45MN/A0.00%N/AN/AN/AN/A
CLVR
CLEVER LEAVES HOLDINGS INC
$3.89MN/A0.00%N/AN/AN/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.39BN/A0.00%N/AN/AN/AN/A
SBFM
SUNSHINE BIOPHARMA INC
$7.45MN/A0.00%N/AN/AN/AN/A
OGI
ORGANIGRAM HOLDINGS INC
$107.86MN/A0.00%N/AN/AN/AN/A
ACOR
ACORDA THERAPEUTICS INC
$12.82MN/A0.00%N/AN/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$23.95MN/A0.00%N/AN/AN/AN/A
OPTN
OPTINOSE INC
$141.51MN/A0.00%N/AN/AN/AN/A
AVDL
AVADEL PHARMACEUTICALS PLC
$1.13BN/A0.00%N/AN/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$52.42MN/A0.00%N/AN/AN/AN/A
PRGO
PERRIGO CO PLC
$4.19B3.53%-3,596.70%$0.2730$1.0961%02023-12-19
KALA
KALA BIO INC
$16.37MN/A0.00%N/AN/AN/AN/A
SXTC
CHINA SXT PHARMACEUTICALS INC
$1.19MN/A0.00%N/AN/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$6.36MN/A0.00%N/AN/AN/AN/A
EVOK
EVOKE PHARMA INC
$4.61MN/A0.00%N/AN/AN/AN/A
ACB
AURORA CANNABIS INC
$196.85MN/A0.00%N/AN/AN/AN/A
CGC
CANOPY GROWTH CORP
$512.37MN/A0.00%N/AN/AN/AN/A
ESPR
ESPERION THERAPEUTICS INC
$163.75MN/A0.00%N/AN/AN/AN/A
CTLT
CATALENT INC
$7.24BN/A0.00%N/AN/AN/AN/A
HCM
HUTCHMED (CHINA) LTD
$3.22BN/A0.00%N/AN/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$8.00MN/A0.00%N/AN/AN/AN/A
PRFX
PAINREFORM LTD
$2.76MN/A0.00%N/AN/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$176.12MN/A0.00%N/AN/AN/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$3.24MN/A0.00%N/AN/AN/AN/A
TKNO
ALPHA TEKNOVA INC
$93.67MN/A0.00%N/AN/AN/AN/A
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
$3.20MN/A0.00%N/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE INC
$83.00MN/A0.00%N/AN/AN/AN/A
DMK
DMK PHARMACEUTICALS CORP
$5.74MN/A0.00%N/AN/AN/AN/A
BFRI
BIOFRONTERA INC
$5.69MN/A0.00%N/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$4.12MN/A0.00%N/AN/AN/AN/A
SCTL
SOCIETAL CDMO INC
$38.25MN/A0.00%N/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$60.26MN/A0.00%N/AN/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$3.26MN/A0.00%N/AN/AN/AN/A
INCR
INTERCURE LTD
$55.14MN/AN/AN/AN/AN/AN/A
FLGC
FLORA GROWTH CORP
$10.67MN/A0.00%N/AN/AN/AN/A
ALVO
ALVOTECH
$2.51BN/A0.00%N/AN/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$2.39MN/A0.00%N/AN/AN/AN/A
COSM
COSMOS HEALTH INC
$15.15MN/A0.00%N/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$81.44MN/A0.00%N/AN/AN/AN/A
SHOT
SAFETY SHOT INC
$193.12MN/A0.00%N/AN/AN/AN/A
AKAN
AKANDA CORP
$1.62MN/A0.00%N/AN/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$141.06MN/A0.00%N/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$6.11BN/A0.00%N/AN/AN/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$123.82MN/A0.00%N/AN/AN/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.61BN/A0.00%N/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$44.46BN/A0.00%$0.4064N/AN/A2
HLN
HALEON PLC
$39.62B0.54%16.40%$0.0460$0.057%0
AQST
AQUESTIVE THERAPEUTICS INC
$159.57MN/A0.00%N/AN/AN/AN/A
HUGE
FSD PHARMA INC
$41.33MN/A0.00%N/AN/AN/AN/A
YCBD
CBDMD INC
$2.00MN/A0.00%N/AN/AN/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$10.88BN/A0.00%$0.0720N/AN/A3
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$2.91BN/A0.00%$0.4750N/AN/A0
BHC
BAUSCH HEALTH COMPANIES INC
$2.69BN/A0.00%N/AN/AN/AN/A
EVO
EVOTEC SE
$3.53BN/AN/AN/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$33.42MN/A0.00%N/AN/AN/AN/A
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$3.71MN/A0.00%N/AN/AN/AN/A
LFCR
LIFECORE BIOMEDICAL INC
$223.17MN/A0.00%N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$52.41MN/A0.00%N/AN/AN/AN/A
INDV
INDIVIOR PLC
$2.32BN/AN/AN/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Dec 2023?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the top pharmaceutical stock with a Zen Score of 59, which is 33 points higher than the pharmaceutical industry average of 26. It passed 21 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -16.64% over the past year, underperforming other pharmaceutical stocks by -3 percentage points.

Viatris has an average 1 year price target of $10.33, an upside of 10.28% from Viatris's current stock price of $9.37.

Viatris stock has a consensus Sell recommendation according to Wall Street analysts. Of the 3 analysts covering Viatris, 0% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 33.33% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the second best pharmaceutical stock with a Zen Score of 53, which is 27 points higher than the pharmaceutical industry average of 26. It passed 18 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock lose -7.28% over the past year, overperforming other pharmaceutical stocks by 7 percentage points.

Neurocrine Biosciences has an average 1 year price target of $130.93, an upside of 11.79% from Neurocrine Biosciences's current stock price of $117.12.

Neurocrine Biosciences stock has a consensus Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Neurocrine Biosciences, 40% have issued a Strong Buy rating, 33.33% have issued a Buy, 26.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third best pharmaceutical stock with a Zen Score of 51, which is 25 points higher than the pharmaceutical industry average of 26. It passed 16 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 11.89% over the past year, overperforming other pharmaceutical stocks by 26 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $36.00, an upside of 40.63% from Collegium Pharmaceutical's current stock price of $25.60.

Collegium Pharmaceutical stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Collegium Pharmaceutical, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 8 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 8.02%, which is 5 percentage points higher than the pharmaceutical industry average of 3.27%.

Siga Technologies's dividend payout ratio of -562.5% indicates that its high dividend yield might not be sustainable for the long-term.

2. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 4.86%, which is 2 percentage points higher than the pharmaceutical industry average of 3.27%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 92.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.41%, which is 1 percentage points higher than the pharmaceutical industry average of 3.27%.

Alkermes's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 1.58% in the last day, and up 1.61% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 71, which is 51 points higher than the pharmaceutical industry average of 20. It passed 5 out of 7 valuation due diligence checks.

Viatris's stock has dropped -16.64% in the past year. It has underperformed other stocks in the pharmaceutical industry by -3 percentage points.

2. Eagle Pharmaceuticals (NASDAQ:EGRX)


Eagle Pharmaceuticals (NASDAQ:EGRX) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Eagle Pharmaceuticals has a valuation score of 71, which is 51 points higher than the pharmaceutical industry average of 20. It passed 5 out of 7 valuation due diligence checks.

Eagle Pharmaceuticals's stock has dropped -83.23% in the past year. It has underperformed other stocks in the pharmaceutical industry by -69 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 57, which is 37 points higher than the pharmaceutical industry average of 20. It passed 4 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 11.89% in the past year. It has overperformed other stocks in the pharmaceutical industry by 26 percentage points.

Are pharmaceutical stocks a good buy now?

56.45% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 52.9% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 16.48x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.